Maryam Lustberg: Vaginal Estrogen Therapy in Females with Breast Cancer
Maryam Lustberg, Director of the Center for Breast Cancer at Smilow Cancer Hospital, posted on LinkedIn:
“Reposting because many with history of breast cancer are still not given the option of vaginal estrogen when non hormonal options fail to work
In this large population based study, vaginal estrogen therapy users compared with nonusers, there was no evidence of a higher risk of breast cancer-specific mortality.”
Dr. Maryam Lustberg is the Director of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center, and Chief of Breast Medical Oncology at Yale Cancer Center. She is also an Associate Professor of Medicine (Medical Oncology).
She has been recognized for her patient-focused care with awards that include being rated by Forbes as one of the top breast medical oncologists in the nation and named to the Castle Connolly list of “Regional Top Doctors,” and “Exceptional Women in Medicine” for 2020.
Dr. Lustberg is a member of the ASCO Annual Meeting Education Committee, Patient and Survivor Care Education Committee, and Neuropathy Expert Guideline Panel. She is the immediate past President for the International Organization Multinational Association of Supportive Care in Cancer (MASCC). She serves as an Associate Editor for the Journal of Cancer Survivorship.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023